Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia

Fig. 1

Concentrations for the five synaptic measures in the AD biomarker group, FTD biomarker group, and controls: a Ng22, b Ng36, c SNAP-25tot, d SNAP-25aa40, and e synaptotagmin-1. Within each group, data points are coloured to represent the clinical phenotype of each participant: purple = bvFTD, yellow = svPPA, green = nfvPPA, blue = lvPPA, orange = PPA-NOS, and black = controls

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193